| Lu, Fang |
NCT03825692: International Clinical Study of Zhizhu Kuanzhong Capsule |
|
|
| Recruiting | 4 | 480 | RoW | Zhizhu Kuanzhong Capsule, ZZKZ capsule, Zhizhu Kuanzhong Placebo Capsule, placebo | Xiyuan Hospital of China Academy of Chinese Medical Sciences | Functional Dyspepsia, Postprandial Distress Syndrome | 12/23 | 12/23 | | |
NCT05520177: A Phase III Study for 601 Versus Ranibizumab in Patients With Vision Loss |
|
|
| Recruiting | 3 | 350 | RoW | 601 1.25mg, 601, ranibizumab 0.5mg, Lucentis | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Branch Retinal Vein Occlusion | 12/25 | 12/25 | | |
| Recruiting | 2 | 54 | RoW | KN046 (Recombinant Humanized PD-L1/CTLA-4 Bispecific Single Domain Antibody Fc Fusion Protein Injection), Axitinib | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Advanced Non-small Cell Lung Cancer | 05/27 | 12/27 | | |
NCT06300476: Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1) |
|
|
| Active, not recruiting | 1/2 | 9 | RoW | JWK006 | West China Hospital | Stargardt Disease 1 | 12/26 | 12/29 | | |
NCT05832684: Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy |
|
|
| Active, not recruiting | 1/2 | 24 | RoW | ZVS101e, rAAV2/8-hCYP4V2, rAAV8-hCYP4V2, AAV8-hCYP4V2 | Chigenovo Co., Ltd | Bietti's Crystalline Dystrophy | 12/24 | 12/28 | | |
NCT06345898: Safety and Efficacy of a Single Subretinal Injection of JWK002 Gene Therapy in Subjects With X-linked Retinoschisis(XLRS) |
|
|
| Recruiting | 1 | 18 | RoW | JWK002 | West China Hospital | X Linked Retinoschisis | 12/26 | 12/29 | | |
